Navigation Links
Phase III data show significant reduction in blood glucose with investigational compound empagliflozin added to metformin or metformin plus sulfonylurea in adults with type 2 diabetes
Date:6/22/2013

ation. Diabetes Atlas, 5th Edition: What is Diabetes? http://www.idf.org/diabetesatlas/5e/what-is-diabetes. Accessed on: June 18, 2013
  • American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013; 36(4):1033-1046.
  • [*]Empagliflozin is an investigational compound. Its safety and efficacy have not been established.

    (Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )
    (Logo: http://photos.prnewswire.com/prnh/20110825/DE57898LOGO )

     


    '/>"/>
    SOURCE Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
    2. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
    3. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
    4. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
    5. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
    6. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
    7. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
    8. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
    9. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
    10. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
    11. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/21/2014)... 2014   Coqui RadioPharmaceuticals Corp. , a medical ... producer of Molybdenum-99 (Mo-99), is proud to announce it ... to design its Medical Isotope Production Facility (MIPF) in ... parent isotope of Technetium-99, which is used in 80 ... passed legislation making it a national priority to produce ...
    (Date:11/21/2014)... 21, 2014  Lexicon Pharmaceuticals, Inc. (Nasdaq: ... announced underwritten public offering of $50,000,000 of shares of ... statement. The offering will consist of 49,751,244 shares of ... per share.  Lexicon has also granted the underwriters a ... of common stock.  All of the shares in the ...
    (Date:11/18/2014)... Mass. , Nov. 18, 2014 Respiratory ... of the leading medical device and services providers in ... exclusive partner for Respiratory Motion,s innovative respiratory depression monitor, ... Motion and IMI are working together to connect the ... has a long history of bringing innovative medical devices ...
    Breaking Medicine Technology:Coqui RadioPharmaceuticals Inks Deal With INVAP 2Lexicon Announces Pricing Of Common Stock Offering 2Lexicon Announces Pricing Of Common Stock Offering 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 2Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 4
    (Date:11/21/2014)... November 21, 2014 Body Well Therapy, a ... it accepts Spafinder massage gift cards and ... hotel massage in all service areas including throughout Florida and ... to go to the spa at all to redeem your ... of Body Well. "We may not be able to transport ...
    (Date:11/21/2014)... Richard Wolfe, co-founder and CEO of ... benefits administration strategies during the Game Changer session ... This Game Changer breakout session enables emerging providers ... solutions and best practices to top HR leaders. ... exchange between health and welfare benefits partners, HR ...
    (Date:11/21/2014)... 21, 2014 Big Bud Farms announced ... episode of Innovations with Ed Begley Jr., airing via ... TBA. , Big Bud Farms, growers of legal medical ... and utilization of medical marijuana. , This segment of ... wide variety of products for medicating. Viewers will learn ...
    (Date:11/21/2014)... 2014 In summer, when it’s hot ... rarely perspire and rarely feel thirsty. As a result, ... eight glasses of fresh water a day recommended for ... advocate Sharon Kleyne. Winter weather is often more dehydrating ... as important.     , The syndicated Sharon ...
    (Date:11/21/2014)... Recently, TideStore.com, a leading online store ... its special offer TideStore Thanksgiving Sales . According ... are now provided with big discounts. The special offer ... enjoy an extra 10% discount with this coupon code: ... and have opportunities to win free gifts. TideStore.com has ...
    Breaking Medicine News(10 mins):Health News:Body Well Mobile Massage Announces Acceptance of Spafinder Gift Cards for In Home Massage, Hotel Massage for Travelers 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 3Health News:Big Bud Farms to be Featured in Upcoming Episode of Innovations with Ed Begley Jr. 2Health News:Our Bodies Need Eight Glasses of Water a Day Even in Winter Reports Fresh Water Advocate 2Health News:Our Bodies Need Eight Glasses of Water a Day Even in Winter Reports Fresh Water Advocate 3Health News:Thanksgiving Sales from TideStore.com 2
    ... which men are at increased risk, scientists say , MONDAY, ... identified key gene variants tied to an increased risk of ... step toward understanding which men are at high risk for ... not been any clear genetic risk factors that can account ...
    ... , RESEARCH TRIANGLE PARK, N.C. , June 1 ... the U.S. Food and Drug Administration has approved Lamictal(R)XR(TM) ... years of age or older with partial onset seizures. Lamictal ... current therapy. , , Lamictal XR reduced the ...
    ... for oncology procedures. , , ST LOUIS, ... that it has entered into an agreement with ... worldwide license to intellectual property from Medtronic related ... Medtronic has developed significant intellectual property in the ...
    ... shows that gay and lesbian couples are forming long-term, ... to marry. However, couples surveyed for the study overwhelmingly ... order to secure legal rights such as retirement ... is both more and less important to gay and ...
    ... Status in 2018, According to a New Report from ... Decision Resources, one of the world,s leading research ... that Amgen,s novel agent denosumab and Eli Lilly,s parathyroid ... percent annual growth in the osteoporosis drug market from ...
    ... --Company Focuses on Rebuilding Revenue Base While Stabilizing ... , VANCOUVER, June 1 /PRNewswire-FirstCall/ - Vancouver, BC, Canada - ... three months ended March 31, 2009. , "The first quarter ... last year to refocus Neovasc on our most promising growth ...
    Cached Medicine News:Health News:Researchers Spot Genes Linked to Testicular Cancer 2Health News:FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy 2Health News:FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy 3Health News:FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy 4Health News:FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy 5Health News:FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy 6Health News:Veran Medical Technologies Announces Intellectual Property Agreement With Medtronic 2Health News:Study shows gay couples want legal rights, regardless of marriage 2Health News:Amgen's Denosumab and Eli Lilly's Forteo/Forsteo Will Drive Robust Annual Growth in the Osteoporosis Drug Market From 2013 to 2018 2Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 2Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 3Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 4Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 5Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 6Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 7Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 8Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 9Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 10Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 11
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: